Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.23% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.41% |
| 4 | Healthcare | 0.83% |
| 5 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
PUT
BridgeBio Pharma
BBIO
$15.4B
| $15.1M | ﹤0.01% |
374,300
-29,000
| -7% | -$871K |
|
|
AVB
2102
CALL
DELISTED
AvalonBay Communities
AVB
| $15.1M | ﹤0.01% |
80,600
-14,100
| -15% | -$2.46M |
|
2103
CALL
Eastman Chemical
EMN
$8.31B
| $15.1M | ﹤0.01% |
168,000
+27,000
| +19% | +$2.15M |
|
2104
CALL
Asana
ASAN
$2.34B
| $15.1M | ﹤0.01% |
793,700
-498,600
| -39% | -$9.7M |
|
2105
Goldman Sachs Access Ultra Short Bond ETF
GSST
$1.61B
| $15.1M | ﹤0.01% |
301,619
+282,295
| +1,461% | +$14.1M |
|
2106
Fair Isaac
FICO
$25B
| $15.1M | ﹤0.01% |
12,949
-987
| -7% | -$993K |
|
|
MRTX
2107
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $15.1M | ﹤0.01% |
256,400
+215,300
| +524% | +$12.1M |
|
2108
CALL
Huntington Bancshares
HBAN
$34.1B
| $15.1M | ﹤0.01% |
1,184,000
+220,200
| +23% | +$2.41M |
|
2109
CALL
TG Therapeutics
TGTX
$8.53B
| $15M | ﹤0.01% |
880,500
+428,400
| +95% | +$4.98M |
|
2110
Martin Marietta Materials
MLM
$37.5B
| $15M | ﹤0.01% |
30,121
-14,364
| -32% | -$6.47M |
|
2111
CALL
Invesco
IVZ
$14.7B
| $15M | ﹤0.01% |
842,000
+713,800
| +557% | +$10.3M |
|
2112
PUT
Ovintiv
OVV
$18B
| $15M | ﹤0.01% |
341,800
-112,600
| -25% | -$5.14M |
|
2113
PUT
Sony
SONY
$141B
| $15M | ﹤0.01% |
791,500
-169,500
| -18% | -$2.94M |
|
2114
iShares Russell 2000 Value ETF
IWN
$14.7B
| $15M | ﹤0.01% |
96,357
-391,189
| -80% | -$54.2M |
|
2115
Celsius Holdings
CELH
$8.35B
| $15M | ﹤0.01% |
274,381
-9,698
| -3% | -$518K |
|
2116
Aflac
AFL
$58.4B
| $15M | ﹤0.01% |
181,270
-93,191
| -34% | -$7.51M |
|
2117
PUT
WEC Energy
WEC
$34.6B
| $14.9M | ﹤0.01% |
177,500
+81,600
| +85% | +$6.72M |
|
2118
PUT
Charles River Laboratories
CRL
$14.2B
| $14.9M | ﹤0.01% |
63,100
-30,700
| -33% | -$6.04M |
|
|
FYBR
2119
CALL
DELISTED
Frontier Communications
FYBR
| $14.9M | ﹤0.01% |
588,400
+103,400
| +21% | +$2.09M |
|
2120
CALL
Markel Group
MKL
$22.4B
| $14.9M | ﹤0.01% |
10,500
+2,200
| +27% | +$3.12M |
|
2121
Surgery Partners
SGRY
$1.82B
| $14.9M | ﹤0.01% |
464,990
-70,285
| -13% | -$2.04M |
|
|
AZEK
2122
DELISTED
The AZEK Co
AZEK
| $14.9M | ﹤0.01% |
388,401
+22,430
| +6% | +$699K |
|
2123
PUT
Inspire Medical Systems
INSP
$1.76B
| $14.9M | ﹤0.01% |
73,000
+20,000
| +38% | +$3.24M |
|
|
LSXMK
2124
PUT
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $14.8M | ﹤0.01% |
515,400
+453,000
| +726% | +$11.9M |
|
2125
iShares Russell 1000 Value ETF
IWD
$84B
| $14.8M | ﹤0.01% |
+89,757
| New | +$13.9M |
|
Similar funds
Jeff Yass's Q4 2023 Portfolio in Review
As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
- Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
- Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.